Enoxacin for Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT04840823 · COMPLETED

Trial details

NCT number: NCT04840823
Sponsor: McGill University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-03-26
Primary completion: 2023-11-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.